Igenica, Inc. is a start-up biopharmaceutical company focused on the creation of breakthrough antibody-based therapeutics to address the unmet medical needs of cancer patients. The company is developing innovative technology platforms for discovering novel tumor antigens and cancer antibodies. Igenica is backed by a strong syndicate of major VC investors and is supported by world-renowned scientific experts and advisors, including Drs. Frederick Appelbaum, David V. Goeddel, Thomas Kipps, Richard Klausner, Jeffrey Ravetch, Robert D. Schreiber, Richard Ulevitch, and Emil Unanue. Igenica is based in the San Francisco Bay Area.

Igenica is currently seeking candidates for the following positions: